<html>
<head>
  <title>1A2</title>
<style>
  .td {font-family: "verdana"; font-size: "10px"; color: "navy";}
  .green {background-color:"#ACA899";font-family:verdana; font-size:8pt;}
  .lite {background-color:"#F1EFE2";font-family:verdana; font-size:8pt; color:"#666600";}
  A:link {COLOR: "navy"; text-decoration: none;}
  A:visited {COLOR: "navy"; text-decoration: none;}
  A:active {COLOR: "navy"; text-decoration: none;}
  A:hover {COLOR:"#66CCFF";}
  .normal {font-family: "verdana"; font-size: 10; color: "#000000";}
</style>
</head>

<body bgcolor="#FFFFFF" class="normal">
<CENTER>
<TABLE border="0" cellPadding="5" cellSpacing="5" width="90%" class="normal">
<tr><td>
<b>References for Cytochrome P450 Drug Interaction Table: 1A2</b><br><br>
	
These pages contain all the literature citations referenced in the Cytochrome P450 Drug Interaction Tables (both the extensive <a HREF="index.htm">research-oriented table</a> and the concise <a HREF="clinlist.htm"> clinical table</a>). Most of these citations are hyperlinks, which bring up the abstract in the NLM's PubMed database.
	
<p>Click on the [ PubMed ] link after the drug name to perform a live MedLINE search of articles possibly related to that drug and Cytochrome P450.</p>

<p>Entries are organized by mode of activity (substrate, inhibitor, inducer) within specific isoform. You can quickly branch to a section by clicking on the appropriate link here:</p>

1A2 | <a href="2B6.htm">2B6</a> | <a href="2C8.htm">2C8</a> | <a href="2C19.htm">2C19</a> | <a href="2C9.htm">2C9</a> | <a href="2D6.htm">2D6</a> | <a href="2E1.htm">2E1</a> | <a href="3A457.htm">3A457</a>

<p>Use Ctrl-F to find all or part of the name or word for which you are searching.</p><br>

<hr color="#33CC66">
<hr color="#FF9900">
<p><h3><a name="3A457sub">1A2 SUBSTRATES</a></h3></p>
<hr color="#FF9900">
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="11amitri"><b>&raquo;&nbsp;AMITRIPTYLINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+amitriptyline+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Fluvoxamine-tricyclic antidepressant interaction. An accidental finding.</td></tr>
<tr class="normal"><td>Authors</td><td>Bertschy G, Vandel S, Vandel B, Allers G, Volmat R</td></tr>
<tr class="normal"><td>Link to Abstract</td><td><a href="">Eur J Clin Pharmacol 1991;40(1):119-120.</a></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic2/alfent.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">


<p>
<a name="11amitri"><b>amitriptyline:</b>
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+amitriptyline+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Fluvoxamine-tricyclic antidepressant interaction. An accidental
finding.</i><br>
Bertschy G, Vandel S, Vandel B, Allers G, Volmat R<br>
Eur J Clin Pharmacol 1991;40(1):119-120. [Letter]
<p>
<a NAME="11caffeine"><b>caffeine:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+caffeine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Determination of urinary metabolites of caffeine for the assessment of
cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in
humans.</i><br>
Rasmussen BB, Brosen K<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8738764&dopt=Abstract">Ther
Drug Monit 1996 Jun;18(3):254-262</a>
<p>
<i>Assays for CYP1A2 by testing in vivo metabolism of caffeine in humans.<br>
</i>Tang BK, Kalow W<i><br>
</i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8791769&dopt=Abstract">Methods
Enzymol 1996;272:124-131</a>
<p>
<a name="11clomip"><b>clomipramine:</b> </a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+clomipramine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Fluvoxamine-tricyclic antidepressant interaction. An accidental
finding.</i><br>
Bertschy G, Vandel S, Vandel B, Allers G, Volmat R<br>
Eur J Clin Pharmacol 1991;40(1):119-120. [Letter]
<p>
<a name="11clozap"><b>clozapine:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+clozapine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolism and bioactivation of clozapine by human liver in vitro.</i><br>
Pirmohamed, M., Williams, D., Madden, S., Templeton, E., and Park, B.K<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=7891353&dopt=Abstract">J
Pharmacol Exp Ther 272(3):984-990, 1995</a>
<p>
<i>Clozapine disposition covaries with CYP1A2 activity determined by a caffeine
test.</i><br>
Bertilsson, L., Carrillo, J.A., Dahl, M.-L., Llerena, A., Alm, C., Bondesson,
U., Lindstrom, L., de la Rubia, I.R., Ramos, S., and Benitez, J<i><br>
</i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=7893591&dopt=Abstract">Br
J Clin Pharmacol 38:471-473, 1994</a>
<p>
<a name="11cyclob"><b>cyclobenzaprine:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cyclobenzaprine&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="11cyclob"><b></b> </a><i>Identification of Human Liver Cytochrome
P450 Isoforms involved in the in vitro metabolism of cyclobenzaprine.</i><br>
Wang RW, Liu L, Cheng H<i><br>
</i>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8818577&dopt=Abstract">Drug
Metab Dispos 1996;24(7):786-791</a>
<p>
<a name="11fluvox"><b>fluvoxamine:</b></a> <a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+fluvoxamine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Disposition of fluvoxamine in humans is determined by the polymorphic
CYP2D6 and also by the CYP1A2 activity.</i><br>
Carillo JA, Dahl M-L, Svennson J-O, Alm C, Rodriguez I, Bertillson L<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8823236&dopt=Abstract">Clin Pharmacol Ther 1996;60:183-190</a>
<p>
<a name="11estrad"><b>estradiol:</b> </a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+estradiol+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation
of oestradiol and 17alpha-ethinyloestradiol.</i><br>
Ball, S.E., Forrester, L.M., Wolf, C.R., and Back, D.J<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=2327982&dopt=Abstract">Biochem
J 267:221-226, 1990</a>
<p>
<a name="11halper"><b>haloperidol:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+haloperidol+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="11halper"></a><i>Coadministration of fluvoxamine increases serum
concentrations of haloperidol.<br>
</i>Daniel, D.G., Randolph, C., Jaskiw, G., Handel, S., Williams, T.,
Abi-Dargham, A., Shoaf, S., Egan, M., Elkashef, A., Liboff, S., and Linnoila,
M<i><br>
</i>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=7806690&dopt=Abstract">J
Clin Psychopharmacol 14:340-343, 1994</a>
<p>
<a NAME="11imipramine"><b>imipramine:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+imipramine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Reappraisal of human CYP isoforms involved in imipramine N-demethylation
and 2-hydroxylation: a study using microsomes obtained from putative extensive
and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.<br>
</i>Koyama E, Chiba K, Tani M, Ishizaki T<i><br>
</i>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=9190854&dopt=Abstract">J
Pharmacol Exp Ther 1997 Jun;281(3):1199-1210</a>
<p>
<i>Major pathway of imipramine metabolism is catalyzed by cytochromes P-450
1A2 and P-450 3A4 in human liver.</i><br>
Lemoine A, Gautier JC, Azoulay D, Kiffel L, Belloc C, Guengerich FP, Maurel
P, Beaune P, Leroux JP<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8502233&dopt=Abstract">Mol
Pharmacol 1993 May;43(5):827-832</a>
<p>
<a name="11mexile"><b>mexiletine:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+mexiletine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>CYP1A2 is the major enzyme involved in the metabolism of mexillitene in man.</i><br>
Abolfathi Z, Pakdel H, Beaune P, Turgeon J<br>
Clin Pharmacol Ther 1995;57(2):215 Abst.
<p>
<i>Ciprofloxacin decreases mexillitene (mex) clearance in smokers and
non-smokers.</i><br>
Labbe L, Lefez C, Gilbert M, O'Hara G, Turgeon J<br>
Clin Pharmacol Ther 1995;57:210 Abst.
<p>
<b><a NAME="11naproxen">naproxen:</a></b><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+naproxen+AND+substrate&doptcmdl=DocSum">PubMed</a></i>

<p>
<i>Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic
O-demethylation of R- and S-naproxen.</i><br>
Miners JO, Coulter S, Tukey RH, Veronese ME, Birkett DJ<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8866821&dopt=Abstract">Biochem
Pharmacol 1996 Apr 26;51(8):1003-1008</a>

<p>
<b><a name="11olanz">olanzapine</a></b><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+olanzapine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
<b><a NAME="11ondansetron">ondansetron (in
part):</a></b><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ondansetron&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Multiple forms of cytochrome P450 are involved in the metabolism of
ondansetron in humans.</i><br>
Dixon CM, Colthup PV, Serabjit-Singh CJ, Kerr BM, Boehlert CC, Park GR, Tarbit
MH<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8591723&dopt=Abstract">Drug
Metab Dispos 1995 Nov;23(11):1225-1230</a>
<p>
<b><a NAME="11phenacetin">phenacetin: </a></b><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+phenacetin+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Specificity of substrate and inhibitor probes for human cytochromes P450
1A1 and 1A2.</i><br>
Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi
LC, Gelboin HV, Miners JO<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8474022&dopt=Abstract">J
Pharmacol Exp Ther 1993 Apr;265(1):401-407</a>
<p>
<a name="11propra"><b>propranolol:</b> </a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+propranolol+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Selective induction of propranolol metabolism by smoking: Additional effects
on renal clearance of metabolites.</i><br>
Walle, U.K., Walle, T., Cowart, T.D., Conradi, E.C., and Gaffney, T.E<i><br>
</i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=3598909&dopt=Abstract">J.
of Pharm. &amp; Exp. Ther. 241:928-933, 1987</a>
<p>
<i>Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties,
and therapeutic efficacy in depressive illness.</i><br>
Benfield, P and Ward A<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=3096686&dopt=Abstract">Drugs
1986;32:313-334</a><br>
[Fluvoxamine is a potent inhibitor of propranolol metabolism in vivo.]
<p>
<b><a NAME="11riluzole">riluzole</a>:</b> <a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+riluzole+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Involvement of human CYP1A isoenzymes in the metabolism and drug interactions
of riluzole in vitro.</i><br>
Sanderink GJ, Bournique B, Stevens J, Petry M, Martinet M<i><br>
</i>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=9316860&dopt=Abstract">J
Pharmacol Exp Ther 1997 Sep;282(3):1465-1472</a>
<p>
<b><a NAME="11ropivacaine">ropivacaine</a>:</b><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ropivacaine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<b></b>M<i>etabolism of ropivacaine in humans is mediated by CYP1A2 and to
a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole
as in vivo inhibitors.</i><br>
Arlander E, Ekstrom G, Alm C, Carrillo JA, Bielenstein M, Bottiger Y, Bertilsson
L, Gustafsson LL<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=9834040&dopt=Abstract">Clin
Pharmacol Ther 1998 Nov;64(5):484-91</a>
<p>
<a name="11tacrin"><b>tacrine:</b> </a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+tacrine+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Determination of human hepatic cytochrome P450 1A2 activity in vitro:
use of tacrine as an isozyme-specific probe.</i><br>
Spaldin V, Madden S, Adams DA, Edwards RJ, Davies DS, Park BK<i><br>
</i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8565783&dopt=Abstract">Drug
Metab Dispos 1995;23(9):929-934</a>

<p>
<a name="11theoph"><b>theophylline:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+theophylline+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolism of theophylline by cDNA-expressed human cytochromes
P450.</i><br>
Ha HR, Chen J, Freiburghaus AU, Follath F<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=7619675&dopt=Abstract">Br J Clin Pharmacol 1995;39:321-326</a>
</p>

<p>
<a name="11tizanidine"><b>tizanidine</b></a>
<i><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+tizanidine+AND+substrate&doptcmdl=DocSum">PubMed</a></i><br><br>
<i>Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.</i><br>
Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15592331">Clin Pharmacol Ther. 2004 Dec;76(6):598-606</a><br><br>

<i>Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.</i><br>
Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15060511">Clin Pharmacol Ther. 2004 Apr;75(4):331-41</a>
</p>

<p>
<a NAME="11verapamil"><b>verapamil:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+verapamil+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>The effect of three different oral doses of verapamil on the disposition
of theophylline.</i><br>
Stringer KA, Mallet J, Clarke M, Lindenfeld JA<i><br>
</i>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=1505606&dopt=Abstract">Eur
J Clin Pharmacol 1992;43(1):35-38</a>
<p>
<i>Verapamil-induced inhibition of theophylline elimination in healthy
humans.</i><br>
Nielsen-Kudsk JE, Buhl JS, Johannessen AC<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=2315261&dopt=Abstract">Pharmacol
Toxicol 1990 Feb;66(2):101-103</a>
<p>
<a NAME="11warfarin"><b>warfarin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+warfarin+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="11zileuton">zileuton:</a> </b><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+zileuton+AND+substrate&doptcmdl=DocSum">PubMed</a></i>
<p>
<b></b><i>Identification of the human liver cytochrome P450 enzymes involved
in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite,
Abbott-66193.</i><br>
Machinist JM, Mayer MD, Shet MS, Ferrero JL, Rodrigues AD<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8654206&dopt=Abstract">Drug
Metab Dispos. 1995 Oct; 23(10): 1163-1174</a>
<p>
<b><a NAME="11zolmit">zolmitriptan:</a><font COLOR="#ff80ff">
</font></b><font COLOR="Blue"><u><i><a HREF="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?CMD=search&amp;DB=PubMed">Pubmed</a></i></u></font>
<p>
<i>Determination of the human cytochrome P450 isoforms involved in the metabolism
of zolmitriptan.</i><br>
Wild MJ, McKillop D, Butters CJ<font COLOR="Blue"><u><br>
<a HREF="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10553725&amp;dopt=Abstract">Xenobiotica.
1999 Aug;29(8):847-57</a></u></font>

<hr color="#33CC66">
<hr color="#FF9900">
<p><h3><a name="3A457sub">1A2 INHIBITORS</a></h3></p>
<hr color="#FF9900">
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="amiodarone"><b>&raquo;&nbsp;AMIODARONE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+amiodarone+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2.</td></tr>
<tr class="normal"><td>Authors</td><td>Kobayashi K, Nakajima M, Chiba K, Yamamoto T, Tani M, Ishizaki T, Kuroiwa Y.</td></tr>
<tr class="normal"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=9578183&dopt=Abstract">Br J Clin Pharmacol 1998 Apr;45(4):361-368.</a></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/amiodarone.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="cimetidine"><b>&raquo;&nbsp;CIMETIDINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cimetidine+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.</td></tr>
<tr class="normal"><td>Authors</td><td>Madeira M, Levine M, Chang TK, Mirfazaelian A, Bellward GD.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16680870&dopt=Abstract">Drug Metab Dispos. 2004 Apr;32(4):460-7.</a><br><br></td></tr>

<tr class="normal"><td>Article</td><td>Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.</td></tr>
<tr class="normal"><td>Authors</td><td>Martínez C, Albet C, Agúndez JA, Herrero E, Carrillo JA, Márquez M, Benítez J, Ortiz JA.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10223772&dopt=Abstract">Clin Pharmacol Ther. 1999 Apr;65(4):369-76.</a><br><br></td></tr>

<tr class="normal"><td>Article</td><td>Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.</td></tr>
<tr class="normal"><td>Authors</td><td>Abernethy DR, Greenblatt DJ, Shader RI.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6726654&dopt=Abstract">J Pharmacol Exp Ther. 1984 Jun;229(3):702-5.</a><br><br></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/cimet.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="ciprofloxacin"><b>&raquo;&nbsp;CIPROFLOXACIN</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ciprofloxacin+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism.</td></tr>
<tr class="normal"><td>Authors</td><td>Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ.</td></tr>
<tr class="normal"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15592331&dopt=Abstract">Clin Pharmacol Ther. 2004 Dec;76(6):598-606.</a></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/cipro.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="fluoro"><b>&raquo;&nbsp;FLUOROQUINOLONES</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+fluoroquinolones+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.</td></tr>
<tr class="normal"><td>Authors</td><td>Batty K, Davis TME, Ilett KF, Dusci LJ, Langton SR.</td></tr>
<tr class="normal"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=7619673&dopt=Abstract">Br J Clin Pharmacol 1995;39(3):305-311.</a></td></tr>
<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/cipro.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<table class="normal">
<tr class="normal"><td width="125"><a name="fluvox"><b>&raquo;&nbsp;FLUVOXAMINE</b></a></td>
<td>[ <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+fluvoxamine+AND+substrate&doptcmdl=DocSum">PubMed</a> ]</td></tr>
<tr class="normal"><td>Article</td><td>Fluvoxamine is a potent inhibitor of cytochrome P4501A2.</td></tr>
<tr class="normal"><td>Authors</td><td>Brosen K, Skjelbo E, Rasmussen BB, Poulsen HE, Loft S.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8466541&dopt=Abstract">Biochem Pharmacol 1993 Mar 24;45(6):1211-1214.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.</td></tr>
<tr class="normal"><td>Authors</td><td>Ball SE, Ahern D, Scatina J, Kao J.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=9205822&dopt=Abstract">Br J Clin Pharmacol. 1997 Jun;43(6):619-26.</a><br><br></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia.</td></tr>
<tr class="normal"><td>Authors</td><td>Chiu CC, Lane HY, Huang MC, Liu HC, Jann MW, Hon YY, Chang WH, Lu ML.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15545309&dopt=Abstract">J Clin Pharmacol. 2004 Dec;44(12):1385-90.<br><br></a></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function.</td></tr>
<tr class="normal"><td>Authors</td><td>Orlando R, Piccoli P, De Martin S, Padrini R, Floreani M, Palatini P.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=14749694&dopt=Abstract">Clin Pharmacol Ther. 2004 Jan;75(1):80-8.<br><br></a></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2.</td></tr>
<tr class="normal"><td>Authors</td><td>Yao C, Kunze KL, Kharasch ED, Wang Y, Trager WF, Ragueneau I, Levy RH.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=11719727&dopt=Abstract">Clin Pharmacol Ther. 2001 Nov;70(5):415-24.<br><br></a></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Effect of fluvoxamine on the pharmacokinetics of mexiletine in healthy Japanese men.</td></tr>
<tr class="normal"><td>Authors</td><td>Kusumoto M, Ueno K, Oda A, Takeda K, Mashimo K, Takaya K, Fujimura Y, Nishihori T, Tanaka K.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=11240973&dopt=Abstract">Clin Pharmacol Ther. 2001 Mar;69(3):104-7.<br><br></a></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo.</td></tr>
<tr class="normal"><td>Authors</td><td>Larsen JT, Hansen LL, Spigset O, Brøsen K.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=10456487&dopt=Abstract">Eur J Clin Pharmacol. 1999 Jul;55(5):375-82.<br><br></a></td></tr>

<tr class="normal" valign="top"><td>Article</td><td>Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans.</td></tr>
<tr class="normal"><td>Authors</td><td>Becquemont L, Ragueneau I, Le Bot MA, Riche C, Funck-Brentano C, Jaillon P.</td></tr>
<tr class="normal" valign="top"><td>Link to Abstract</td><td><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=9209244&dopt=Abstract"> Clin Pharmacol Ther. 1997 Jun;61(6):619-27.<br><br></a></td></tr>

<tr class="normal"><td>Info</td><td><a href="http://www.rxlist.com/cgi/generic/fluvox.htm">www.rxlist.com</a></td></tr>
</table>
<hr color="#33CC66">

<p>
<a name="12furafy"><b>furafylline:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+furafylline+AND+inhibitor&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="12furafy"></a><i>Furafylline is a potent and selective inhibitor
of P4501A2 in man.</i><br>
Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies
DS<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=2378786&dopt=Abstract">Br
J Clin Pharmacol 1990;29:651-663</a>
<p>
<a name="12interf"><b>interferon:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+interferon+AND+inhibitor&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="12interf"></a><i>Regulation of hepatic cytochrome P-450 during
infectious disease</i><br>
Renton KW, Knickle LC<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=1695539&dopt=Abstract">Can
J Physiol Pharmacol 1990 Jun;68(6):777-781</a>
<p>
<a NAME="12methoxsalen"><b>methoxsalen:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+methoxsalen+AND+inhibitor&doptcmdl=DocSum">PubMed</a></i>
<p>
<a NAME="12mibefradil"><b>mibefradil:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+mibefradil+AND+inhibitor&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Metabolism of the calcium antagonist, mibefradil (POSICOR,Ro40-5967).
Part III. Comparative pharmacokinetics of mibefradil and its major metabolites
in rat, marmoset, cynomolgus monkey and man.</i><br>
Wiltshire HR, Sutton BM, Heeps G, Betty AM, Angus DW, Harris SR, Worth E,
Welker HA<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=9211656&dopt=Abstract">Xenobiotica
1997 Jun;27(6):557-571</a>
<p>
<a name="12ticlop"><b>ticlopidine:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+ticlopidine+AND+inhibitor&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Ticlopidine-theophylline interaction.</i><br>
Colli A, Buccino G, Cocciollo M, Parravicini R, Elli GM, Scaltrini G<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=3816023&dopt=Abstract">Clin
Pharmacol Ther 1987; 41: 358-362</a>

<p>
  <hr>
  <a NAME="1A2ind"><img src="1A2inducers.jpg"></a>
<p>

<a NAME="13broccoli"><b>broccoli:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+broccoli+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="13brussel">brussel sprouts:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+brussel+AND+sprouts+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="13charmeat">char-grilled meat:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+chargrilled+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and
P-glycoprotein levels in healthy volunteers.</i><br>
Fontana RJ, Lown KS, Paine MF, Fortlage L, Santella RM, Felton JS, Knize
MG, Greenberg A, Watkins PB<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=10381914&dopt=Abstract">Gastroenterology
1999 Jul;117(1):89-98 </a>
<p>
<a name="13insuli"><b>insulin:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+insulin+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Hyperinsulinemia causes a preferential increase in hepatic P4501A2
activity.</i><br>
Barnett CR, Wilson J, Wolf CR, Flatt PR, Ioannides C<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=1562279&dopt=Abstract">Biochem
Pharmacol 1992;43(6):1255-61</a>
<p>
<a NAME="13methylcholanthrene"><b>methyl cholanthrene:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cholanthrene+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="13modafinil">modafinil</a></b>:
<u><a HREF="http://www.provigil.com/interactions.htm">Info</a></u>
&nbsp;<font COLOR="Blue"><i><u><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+modafinil+AND+inducer&doptcmdl=DocSum">PubMed</a></u></i></font>
<p>
<i>In vitro inhibition and induction of human hepatic cytochrome P450 enzymes
by modafinil.</i><br>
Robertson P, DeCory HH, Madan A, Parkinson
A.<br>
<font COLOR="Blue"><u><a HREF="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10820139&amp;dopt=Abstract">Drug
Metab Dispos 2000 Jun;28(6):664-71</a></u></font>
<p>
<a NAME="13nafcillin"><b>nafcillin:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+nafcillin+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<b><a NAME="13betanaphthoflavone">beta-naphthoflavone:</a></b>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+naphthoflavone+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<a NAME="13omeprazole"><b>omeprazole:</b></a>
<i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+omeprazole+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<a name="13tobacc"><b>tobacco:</b></a><a name="11amitri">
</a><i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+tobacco+AND+inducer&doptcmdl=DocSum">PubMed</a></i>
<p>
<i>Effect of smoking on caffeine clearance.</i><br>
Parsons WD, Neims AH<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=657717&dopt=Abstract">Clin
pharmacol Ther 1978;24(1):40-45</a>
<p>
<i>Assessment of the cytochrome P-448 dependent liver enzyme system by a
caffeine breath test.</i><br>
Wietholz H, Voegelin M, Arnaud MJ, Bircher J, Preisig R<br>
<a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=6800827&dopt=Abstract">Eur
J Clin Pharmacol 1981;21:53-59</a>

</td>
</tr>
</table>
<p ALIGN="Center">
<font face="Verdana, Arial, Helvetica, sans-serif" size="-1"><i>Updated: 09/2003</i></font>
<p>
</body></html>
